{"id":197764,"date":"2021-10-01T18:38:02","date_gmt":"2021-10-01T18:38:02","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=197764"},"modified":"2021-10-01T18:38:02","modified_gmt":"2021-10-01T18:38:02","slug":"raliu-de-peste-8-pe-actiunile-merck-gigantul-farmaceutic-care-sustine-ca-a-creat-primul-medicament-anti-covid-19-ce-reduce-cu-50-riscul-de-spitalizare-si-deces-scaderi-pe-actiunile-principalilor-pro","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=197764","title":{"rendered":"Raliu de peste 8% pe ac\u0163iunile Merck, gigantul farmaceutic care sus\u0163ine c\u0103 a creat primul medicament anti-Covid-19 ce reduce cu 50% riscul de spitalizare \u015fi deces. Sc\u0103deri pe ac\u0163iunile principalilor produc\u0103tori de vaccinuri anti-coronavirus"},"content":{"rendered":"<p>\nAc\u0163iunile gigantului farmaceutic Merck (simbol bursier MRK) au crescut cu peste 8% \u00een New York, dup\u0103 ce compania a anun\u0163at c\u0103 a dezvoltat \u00eempreun\u0103 cu Ridgeback Biotherapeutics un medicament anti-Covid-19 care reduce cu 50% riscul de spitalizare \u015fi deces.<\/p>\n<p>\nDac\u0103 va fi autorizat, tratamentul \u2013 numit Molnupiravir \u2013 va deveni primul medicament antiviral cu administrare oral\u0103 care poate combate coronavirusul.<\/p>\n<p>\nMerck este prima companie farmaceutic\u0103 din lume, \u00eenfiin\u0163at\u0103 \u00een urm\u0103 cu 353 de ani de Friedrich Jacob Merck. \u00cen prezent, capitalizarea societ\u0103\u0163ii ajunge la 205 miliarde de dolari.<\/p>\n<p>\nCererea de utilizare \u00een caz de urgen\u0163\u0103 \u201eva veni \u00een cur\u00e2nd\u201d, au spus Merck \u015fi Ridgeback. Totu\u015fi, un comitet independent de monitorizare a datelor, \u00een colaborare cu FDA (Agen\u0163ia american\u0103 pentru Alimente \u015fi Medicamente), le-a recomandat celor dou\u0103 companii s\u0103 \u00eenceteze procesele de recrutare pentru ultima etap\u0103 de testare a pilulei, not\u00e2nd \u00een acest sens faptul c\u0103 rezultatele au la baz\u0103 o analiz\u0103 interimar\u0103, potrivit Business Insider.<\/p>\n<p>\nAst\u0103zi, ac\u0163iunile Moderna \u2013 unul dintre principalii produc\u0103tori de vaccinuri anti-coronavirus \u2013 au sc\u0103zut cu 14%, iar Pfizer a \u00eenregistrat un minus de peste 2%. Totodat\u0103, ac\u0163iunile Johnson &#038; Johnson s-au depreciat cu 1,2%.<\/p>\n<p>\nPie\u0163ele nu au \u00eent\u00e2rziat s\u0103 reac\u0163ioneze, principalii indici bursieri din Statele Unite deschiz\u00e2nd pe plus \u015fedin\u0163a de tranzac\u0163ionare de vineri, 1 octombrie. De asemenea, evolu\u0163iile vin \u00een contextul \u00een care investitorii \u00eencearc\u0103 s\u0103 profite de ocazie \u015fi s\u0103 cumpere ac\u0163iuni prezente \u00een sectoare care au \u00eenregistrat sc\u0103deri \u00een luna septembrie.<\/p>\n<p>\nIndicele bursier Dow Jones a crescut p\u00e2n\u0103 la ora public\u0103rii \u015ftirii cu 0,7%, \u00een timp ce S&#038;P 500 s-a apreciat cu 0,35%. Nasdaq, indicele marilor companii tech, a \u00eenregistrat o evolu\u0163ie neglijabil\u0103, de 0,03%.<\/p>\n<p>\n&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ac\u0163iunile gigantului farmaceutic Merck (simbol bursier MRK) au crescut cu peste 8% \u00een New York, dup\u0103 ce compania a anun\u0163at c\u0103 a dezvoltat \u00eempreun\u0103 cu Ridgeback Biotherapeutics un medicament anti-Covid-19 care reduce cu 50% riscul de spitalizare \u015fi deces. Dac\u0103 va fi autorizat, tratamentul \u2013 numit Molnupiravir \u2013 va deveni primul medicament antiviral cu administrare [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[7172,8337,18324,323,10209,26190],"class_list":["post-197764","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-actiuni","tag-evolutie","tag-infiintare","tag-medicamente","tag-new-york","tag-raliu"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/197764","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=197764"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/197764\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=197764"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=197764"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=197764"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}